317 related articles for article (PubMed ID: 35955410)
1. Lysophosphatidylcholine: Potential Target for the Treatment of Chronic Pain.
Ren J; Lin J; Yu L; Yan M
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955410
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and atherogenic disease association of lysophosphatidylcholine.
Schmitz G; Ruebsaamen K
Atherosclerosis; 2010 Jan; 208(1):10-8. PubMed ID: 19570538
[TBL] [Abstract][Full Text] [Related]
3. The mechanisms of lysophosphatidylcholine in the development of diseases.
Liu P; Zhu W; Chen C; Yan B; Zhu L; Chen X; Peng C
Life Sci; 2020 Apr; 247():117443. PubMed ID: 32084434
[TBL] [Abstract][Full Text] [Related]
4. Role of lysophosphatidylcholine (LPC) in atherosclerosis.
Matsumoto T; Kobayashi T; Kamata K
Curr Med Chem; 2007; 14(30):3209-20. PubMed ID: 18220755
[TBL] [Abstract][Full Text] [Related]
5. An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases.
Law SH; Chan ML; Marathe GK; Parveen F; Chen CH; Ke LY
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845751
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis.
Kougias P; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
Med Sci Monit; 2006 Jan; 12(1):RA5-16. PubMed ID: 16369478
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced lipoprotein-associated phospholipase A2 increases lysophosphatidylcholine and induces endothelial cell damage.
Kim SR; Heo JI; Park JW; Kang CM; Kim KS
Toxicology; 2021 Jun; 458():152841. PubMed ID: 34216699
[TBL] [Abstract][Full Text] [Related]
8. Endothelins specifically recognize lysophosphatidylcholine micelles.
Sato A; Ebina K
J Pept Sci; 2013 Jun; 19(6):355-61. PubMed ID: 23576491
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine promotes intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells via an orphan G protein receptor 2-mediated signaling pathway.
Zhang Q; Zhang W; Liu J; Yang H; Hu Y; Zhang M; Bai T; Chang F
Bioengineered; 2021 Dec; 12(1):4520-4535. PubMed ID: 34346841
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2.
Millanvoye-Van Brussel E; Topal G; Brunet A; Do Pham T; Deckert V; Rendu F; David-Dufilho M
Biochem J; 2004 Jun; 380(Pt 2):533-9. PubMed ID: 14992685
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine triggers cell differentiation in the protozoan parasite Herpetomonas samuelpessoai through the CK2 pathway.
Dutra FL; Vieira DP; Coelho FS; Adade CM; Atella GC; Silva Neto MAC; Lopes AH
Acta Parasitol; 2020 Mar; 65(1):108-117. PubMed ID: 31755068
[TBL] [Abstract][Full Text] [Related]
12. Effect of lysophosphatidylcholine on transmembrane signal transduction.
Prokazova NV; Zvezdina ND; Korotaeva AA
Biochemistry (Mosc); 1998 Jan; 63(1):31-7. PubMed ID: 9526092
[TBL] [Abstract][Full Text] [Related]
13. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
Korotaeva AA; Cheglakov IB; Morozkin AD; Suslova IV; Prokazova NV
Membr Cell Biol; 1997; 10(5):521-34. PubMed ID: 9225256
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Cardiovasc Pharmacol; 2002 Mar; 39(3):449-59. PubMed ID: 11862125
[TBL] [Abstract][Full Text] [Related]
15. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes.
Sevastou I; Kaffe E; Mouratis MA; Aidinis V
Biochim Biophys Acta; 2013 Jan; 1831(1):42-60. PubMed ID: 22867755
[TBL] [Abstract][Full Text] [Related]
16. Modulation of nonselective cation current by oxidized LDL and lysophosphatidylcholine and its inhibitory contribution to endothelial damage.
Liang GH; Park S; Kim MY; Kim JA; Choi S; Suh SH
Life Sci; 2010 May; 86(19-20):733-9. PubMed ID: 20226792
[TBL] [Abstract][Full Text] [Related]
17. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
Murohara T; Kugiyama K; Ohgushi M; Sugiyama S; Ohta Y; Yasue H
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2441-9. PubMed ID: 7810742
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Native- and Oxidized-Low-Density Lipoprotein with Human Estrogen Sulfotransferase.
Sato A; Watanabe H; Yamazaki M; Sakurai E; Ebina K
Protein J; 2021 Apr; 40(2):192-204. PubMed ID: 33665770
[TBL] [Abstract][Full Text] [Related]
19. Secretory phospholipases A2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor.
Ikeno Y; Konno N; Cheon SH; Bolchi A; Ottonello S; Kitamoto K; Arioka M
J Biol Chem; 2005 Jul; 280(30):28044-52. PubMed ID: 15927955
[TBL] [Abstract][Full Text] [Related]
20. Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells.
Naito M; Yamada K; Hayashi T; Asai K; Yoshimine N; Iguchi A
Heart Vessels; 1994; 9(4):183-7. PubMed ID: 7961295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
